315 related articles for article (PubMed ID: 25622927)
1. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Papatheodorou A; Patsiaoura K; Katsiki E; Zafeiriadou E; Zavos C; Anastasiadou K; Terpos E
Metabolism; 2013 Jan; 62(1):121-6. PubMed ID: 22841522
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.
Baeg MK; Yoon SK; Ko SH; Noh YS; Lee IS; Choi MG
World J Gastroenterol; 2016 Feb; 22(8):2592-600. PubMed ID: 26937147
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.
Polyzos SA; Nikolopoulos P; Stogianni A; Romiopoulos I; Katsinelos P; Kountouras J
Arq Gastroenterol; 2014; 51(3):261-8. PubMed ID: 25296089
[TBL] [Abstract][Full Text] [Related]
5. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
[TBL] [Abstract][Full Text] [Related]
6. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
Kim TJ; Sinn DH; Min YW; Son HJ; Kim JJ; Chang Y; Baek SY; Ahn SH; Lee H; Ryu S
J Gastroenterol; 2017 Nov; 52(11):1201-1210. PubMed ID: 28382402
[TBL] [Abstract][Full Text] [Related]
7. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Patsiaoura K; Katsiki E; Zafeiriadou E; Deretzi G; Zavos C; Gavalas E; Katsinelos P; Mane V; Slavakis A
Ann Hepatol; 2012; 11(1):68-76. PubMed ID: 22166563
[TBL] [Abstract][Full Text] [Related]
8. Relevance between Helicobacter
Mohammadifard M; Saremi Z; Rastgoo M; Akbari E
J Med Life; 2019; 12(2):168-172. PubMed ID: 31406519
[TBL] [Abstract][Full Text] [Related]
9. The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population.
Yu YY; Cai JT; Song ZY; Tong YL; Wang JH
Medicine (Baltimore); 2018 Nov; 97(46):e13271. PubMed ID: 30431613
[TBL] [Abstract][Full Text] [Related]
10. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.
Tang DM; Kumar S
Curr Gastroenterol Rep; 2017 Feb; 19(2):5. PubMed ID: 28155087
[TBL] [Abstract][Full Text] [Related]
11. Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori.
Lee HY; Kim JW; Lee JK; Heo EY; Chung HS; Kim DK
Int J Chron Obstruct Pulmon Dis; 2016; 11():2055-62. PubMed ID: 27621611
[TBL] [Abstract][Full Text] [Related]
12. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
Kamada Y; Akita M; Takeda Y; Yamada S; Fujii H; Sawai Y; Doi Y; Asazawa H; Nakayama K; Mizutani K; Fujii H; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
PLoS One; 2013; 8(6):e66328. PubMed ID: 23805214
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
14. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
Kang SJ; Kim HJ; Kim D; Ahmed A
PLoS One; 2018; 13(8):e0202325. PubMed ID: 30110395
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?
Abdel-Razik A; Mousa N; Shabana W; Refaey M; Elhelaly R; Elzehery R; Abdelsalam M; Elgamal A; Nassar MR; Abu El-Soud A; Seif AS; Tawfik AM; El-Wakeel N; Eldars W
Helicobacter; 2018 Dec; 23(6):e12537. PubMed ID: 30246507
[TBL] [Abstract][Full Text] [Related]
16. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
17. High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity.
Kakisaka K; Sasaki A; Umemura A; Nikai H; Suzuki Y; Nishiya M; Sugai T; Nitta H; Takikawa Y
Sci Rep; 2021 Jul; 11(1):15392. PubMed ID: 34321567
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis markers of nonalcoholic steatohepatitis.
Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease.
Kakisaka K; Suzuki Y; Fujiwara Y; Abe T; Yonezawa M; Kuroda H; Ishida K; Sugai T; Takikawa Y
J Gastroenterol; 2018 Dec; 53(12):1285-1291. PubMed ID: 29680867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
